An Academic-Industry Partnership (AIP) led by Dartmouth researchers received a $3 million grant from the National Cancer Institute to develop a superior breast diagnostic technology. More specifically, the team seeks to pursue the idea of developing a multi-model...
A study led by an investigator with ChristianaCare’s Helen F. Graham Cancer Center & Research Institute concludes that the radiation used to treat breast cancer by killing cancer cells can cause side effects, including inflammation, which in turn can introduce a...
The WISDOM study represents a groundbreaking effort to determine the optimal guidelines for breast cancer screening and now seeks qualifying women across the country that would like to contribute to improving breast cancer screening and prevention. WISDOM was recently...
UT Southwestern Simmons Cancer Center researchers have discovered a two-drug combination that halts the growth of cancer cells that carry HER2 mutations. Patients with cancers harboring HER2 mutations eventually develop resistance to a promising new cancer drug...
Medicaid and Medicare beneficiaries are more likely to die from breast cancer or stop treatment early than those women who are on commercial insurance based on the results of a study of 10,000 women presented on December 12, at the San Antonio Breast Cancer...
Laura Holmes Haddad was diagnosed with Stage IV inflammatory breast cancer at 37—the mom of two children ages 1 and 4. A rare and aggressive form of cancer attacking the lymphatic system near the breast, it is a deadly form of the disease—typically far distributed...
